Adverum Biotechnologies Announces Positive Preliminary Effic

Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD

Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , Arshad Khanani , Arshadm Khanani , Laurent Fischer , Nasdaq , Clinical Research At Sierra Eye Associates , Healthcare Products Regulatory Agency , Clinical Associate Professor At University Of Nevada , Adverum Biotechnologies Inc , Meeting Of The Macula Society , Exchange Commission , Safety Data , Annual Meeting , Intravitreal Gene Therapy , Neovascular Age Related Macular Degeneration , Preliminary Results , Managing Partner , Clinical Research , Sierra Eye Associates , Clinical Associate Professor , Principal Investigator , Fast Track , Innovation Passport , Private Securities Litigation Reform Act , Quarterly Report ,